The Nifty Pharma index closed on a negative note on Wednesday. Shares of Mankind Pharma Ltd.(up 0.24 per cent), Biocon ...

AM(IST)on Monday in an upbeat market. Gland Pharma Ltd.(up 2.26 per cent), Laurus Labs Ltd.(up 2.02 per cent), J B Chemicals ...

Resmetirom is a medication approved by the FDA to treat adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with ...

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

Here are the local and international drugmakers also eyeing the Indian market and looking to introduce rivals to Lilly's drug ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

TiumBio (KOSDAQ: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative ...

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 ...

Based on the reciprocal tariff approach, a 10% tariff on Indian pharma imports could be a possibility, but BofA cites a few ...

IST, the barometer index, the S&P BSE Sensex, advanced 291.97 points or 0.43% to 74,143.70. The Nifty 50 index added 95.30 points or 0.43% to 22,492.50.

The respiratory segment, often influenced by seasonal factors, registered a 1.1% increase in value but faced a 4.6% decline ...